child development

In Brief: Study Finds No Link Between Antipsychotics and Gestational Diabetes

Given the number of younger women using atypical antipsychotic medications, we need more accurate data regarding the reproductive safety of these medications. To better understand the link between antipsychotic medication and medical conditions associated with [...]

By |2020-01-25T23:48:54-04:00May 18th, 2015|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Pregnancy Outcomes|Comments Off on In Brief: Study Finds No Link Between Antipsychotics and Gestational Diabetes

Prenatal Cocaine Exposure and Its Effect on the Developing Brain

Prenatal cocaine exposure or PCE occurs when a child is exposed in utero to cocaine taken by the pregnant mother.  We know that cocaine exposure during pregnancy can negatively affect the pregnancy; women who use [...]

By |2015-07-08T11:10:31-04:00May 12th, 2015|Child Outcomes, Cocaine, Perinatal Substance Use|Comments Off on Prenatal Cocaine Exposure and Its Effect on the Developing Brain

Meta-Analysis: Antipsychotics and Pregnancy Outcomes

Second-generation or “atypical” antipsychotics, such as olanzapine (Zyprexa), aripiprazole (Abilify), and risperidone (Risperdal), are used far more frequently than are the first-generation or “typical” antipsychotics, such as haloperidol (Haldol). This is largely because the newer [...]

By |2015-07-08T11:30:14-04:00May 6th, 2015|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Meta-Analysis: Antipsychotics and Pregnancy Outcomes

Parental Age and Risk of ADHD in Children

Many studies have examined the association between parental age and psychiatric illness in the children, including autism and schizophrenia.  In a recent case-control study from Finland, the authors identified 10,409 individuals with ADHD born between 1991 and 2005 from nationwide population-based registers.  Logistic regression was used to examine the association between parental age and ADHD in the offspring, adjusting for potential confounding factors including parental psychiatric history, maternal socioeconomic status, marital status, maternal smoking during pregnancy, number of previous births, and birth weight.

By |2015-07-08T14:07:59-04:00April 7th, 2015|Neurodevelopmental Disorders, Outcomes, Psychiatric Disorders During Pregnancy|Comments Off on Parental Age and Risk of ADHD in Children

Understanding the Link Between Maternal Diet, Depression and Child Development

While the human brain continues develop throughout the first twenty or so years of life, the most vulnerable periods of brain development occur during pregnancy and the first 2 to 3 years of the child’s [...]

By |2014-03-13T09:26:59-04:00March 17th, 2014|Child Outcomes, Outcomes, Psychiatric Disorders During Pregnancy|Comments Off on Understanding the Link Between Maternal Diet, Depression and Child Development

Postpartum Depression Associated with Short Stature in Children

We write often here about the negative effects of postpartum depression on the child.  Most of the studies thus far have focused on behavior and cognitive development; a recent study from researchers at JohnsHopkinsUniversity suggests that being exposed to maternal depression during the first year of life may negatively affect the physical development of the child as well.

By |2015-08-06T09:13:15-04:00July 29th, 2013|Postpartum Psychiatric Disorders|Comments Off on Postpartum Depression Associated with Short Stature in Children

Prevalence and Trends in the Use of Antipsychotic Medications during Pregnancy

Since their introduction in the 1990s, atypical (second-generation) antipsychotics have replaced typical (first generation) antipsychotics as the first-line treatment for schizophrenia and related psychotic disorders. These drugs are widely used by reproductive age women across many other disease states including bipolar disorder, major depression and anxiety disorders as either primary or adjunctive treatments.

By |2024-04-14T16:17:44-04:00June 10th, 2013|Antipsychotic Medications, Pregnancy & Medications|Comments Off on Prevalence and Trends in the Use of Antipsychotic Medications during Pregnancy

Atypical Antipsychotic Medications: What Do We Know About Their Reproductive Safety?

Atypical antipsychotic medications are commonly used for the treatment of schizophrenia and bipolar disorder.  Despite the increasing use of these medications in women of child-bearing age, there is still relatively little data regarding the reproductive safety and long-term neurodevelopmental effects of these medications. A recent study assessed the development of 76 infants with fetal exposure to atypical antipsychotics.

By |2015-08-06T10:39:32-04:00May 15th, 2013|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Atypical Antipsychotic Medications: What Do We Know About Their Reproductive Safety?

Father’s Psychological Health and Its Impact on Child Development

While much attention has focused on the impact of maternal psychiatric illness on the well-being of the child, less is known about the impact of psychiatric illness in the father.  A large population-based study from Norway examines the association between symptoms of psychological distress in expectant fathers and socioemotional and behavioral outcomes in their children at 36 months of age.

By |2017-03-28T09:56:33-04:00January 22nd, 2013|Child Outcomes, Depressive Disorders, Outcomes, Postpartum Psychiatric Disorders|Comments Off on Father’s Psychological Health and Its Impact on Child Development
Go to Top